Origen Catheters Recalled Following Reports of Adverse Events

Washington, DC: OriGen Biomedical in conjunction with the US Food and Drug Administration (FDA) is recalling two lots of VV28F Reinforced Dual Lumen ECMO Catheters N18487 and N18487-1 following reports of adverse events associated with the devices.

OriGen Biomedical is aware of two product failures and has received a complaint associated with each of the two product failures. A recurrence of this event could result in serious patient injury, according to the recall notice on the FDA website.

The OriGen RDLC catheter is indicated for use as a single cannula for both venous drainage and arterial re-infusion of blood in the internal jugular vein during extracorporeal life support procedures of six hours or less (USA) or less than 29 days (rest of world).

Legal Help

If you or a loved one has suffered similar damages or injuries, please fill in our form and your complaint will be sent to a lawyer who may evaluate your claim at no cost or obligation.
Last updated on Sep-29-17